Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Cardiology

  • News

    Mortality differs by LVEF between women and men

    June 12, 2020

    An Australian big-data study shows that a left-ventricular ejection fraction above 70% in women spells trouble

  • 1
    News

    Aspirin and warfarin together leads to increased bleeding without reducing thrombotic events

    June 9, 2020

    In patients taking warfarin for atrial fibrillation (AFib) or venous thromboembolism (VTE), how often is aspirin used without a clear indication, and what are the clinical outcomes for these patients?

  • 1
    News

    Catheter ablation of AFib improves quality of life more than medications do

    June 8, 2020

    Does catheter ablation of atrial fibrillation (AFib) improve quality of life (QOL) compared to medication therapy?

  • 1
    News

    QI initiative can decrease unnecessary IV treatment of asymptomatic hypertension

    June 5, 2020

    How common is treatment of asymptomatic hypertension in the hospital with IV medications and what is the impact of a quality improvement initiative to reduce use?

  • News

    Lancet, NEJM retract studies on hydroxychloroquine for COVID-19

    June 4, 2020

    The Lancet issued a retraction of an influential study of hydroxychloroquine use in COVID-19 patients. Hours later, NEJM retracted a second study from the same group.

  • 1
    News

    More fatalities in heart transplant patients with COVID-19

    June 4, 2020

    A new study suggests a high risk for death if heart transplant patients contract COVID-19, which points to the need for increased precautions and vigilance.

  • 1
    News

    Ticagrelor gets FDA nod for DAPT in high-risk patients with CAD

    June 2, 2020

    The new indication is based on THEMIS, which comprised patients with CAD and type 2 diabetes without previous MI or stroke and showed clinical benefit, but also bleeding concerns.

  • News

    FDA okays emergency use for Impella RP in COVID-19 right heart failure

    June 2, 2020

    The authorization allows use of the temporary heart pump in the treatment of right heart failure or decompensation, including pulmonary embolism, caused by COVID-19 complications.

  • 1
    News

    Early or delayed cardioversion in recent-onset atrial fibrillation

    May 29, 2020

    Is immediate restoration of sinus rhythm necessary in early-onset symptomatic atrial fibrillation (AFib)?

  • 1
    Video

    More evidence hydroxychloroquine is ineffective, harmful in COVID-19

    May 27, 2020

    New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.

Previous1 … 30 31 32 33 34 … 79Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences